Cutting Difficult Targets Down To Size: The Evolution Of G Protein Coupled Receptor (GPCR) Selection

Biologics manufacturers are struggling with the tedious and inefficient antibody discovery processes, and these problems are only compounded when working with difficult targets. Targets such as G protein-coupled receptors (GPCRs) can be challenging to prepare and isolate, and have a small, exposed area of extracellular epitope.

Find out how Bruker 's function-first workflow could help set your GPCR pipeline free. Discover a plasma B discovery workflow that addresses these problems by using cutting edge single-cell screening technology to revolutionize antibody discovery. The single-cell screening technology will not only cut down the time from harvesting to lead molecule selection to just one week, it also significantly increases the quantity of quality hits.